本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcutis Biotherapeutics Inc.

26.14
+2.6311.19%
盤前26.390.2500+0.96%04:27 EDT
成交量:515.61萬
成交額:1.31億
市值:32.69億
市盈率:121.35
高:26.39
開:23.63
低:23.63
收:23.51
52周最高:31.77
52周最低:16.57
股本:1.25億
流通股本:1.11億
量比:2.22
換手率:4.64%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
淨資產收益率:15.86%
總資產收益率:5.09%
市淨率:14.82
市盈率(LYR):-206.05

資料載入中...

2026/06/09

重要事件披露

Form 8-K - Current report
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/21

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities